116 related articles for article (PubMed ID: 20722399)
1. Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth.
Gan N; Sun X; Song L
Chem Res Toxicol; 2010 Sep; 23(9):1477-84. PubMed ID: 20722399
[TBL] [Abstract][Full Text] [Related]
2. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.
Yang X; Wang D; Ma Y; Xu X; Zhu Z; Wang X; Deng H; Li C; Chen M; Tong J; Yamanaka K; An Y
Toxicol Appl Pharmacol; 2015 Dec; 289(2):231-9. PubMed ID: 26420645
[TBL] [Abstract][Full Text] [Related]
3. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling.
Lee HH; Park SA; Almazari I; Kim EH; Na HK; Surh YJ
Arch Biochem Biophys; 2010 Sep; 501(1):142-50. PubMed ID: 20558128
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate attenuates microcystin-LR-induced apoptosis in human umbilical vein endothelial cells through activation of the NRF2/HO-1 pathway.
Shi J; Zhang M; Zhang L; Deng H
Environ Pollut; 2018 Aug; 239():466-472. PubMed ID: 29679944
[TBL] [Abstract][Full Text] [Related]
5. 4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.
Tang C; Wang X; Xie Y; Cai X; Yu N; Hu Y; Zheng Z
Cell Physiol Biochem; 2018; 51(2):979-990. PubMed ID: 30466076
[TBL] [Abstract][Full Text] [Related]
6. Prodigiosin Promotes Nrf2 Activation to Inhibit Oxidative Stress Induced by Microcystin-LR in HepG2 Cells.
Chen J; Li Y; Liu F; Hou DX; Xu J; Zhao X; Yang F; Feng X
Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31336817
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells.
Li CQ; Kim MY; Godoy LC; Thiantanawat A; Trudel LJ; Wogan GN
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14547-51. PubMed ID: 19706542
[TBL] [Abstract][Full Text] [Related]
8. Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.
Zhan L; Zhang H; Zhang Q; Woods CG; Chen Y; Xue P; Dong J; Tokar EJ; Xu Y; Hou Y; Fu J; Yarborough K; Wang A; Qu W; Waalkes MP; Andersen ME; Pi J
Free Radic Biol Med; 2012 Aug; 53(4):758-68. PubMed ID: 22684020
[TBL] [Abstract][Full Text] [Related]
9. HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway.
Ade N; Leon F; Pallardy M; Peiffer JL; Kerdine-Romer S; Tissier MH; Bonnet PA; Fabre I; Ourlin JC
Toxicol Sci; 2009 Feb; 107(2):451-60. PubMed ID: 19033392
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
[TBL] [Abstract][Full Text] [Related]
11. Propofol pretreatment attenuates remote kidney injury induced by orthotopic liver autotransplantation, which is correlated with the activation of Nrf2 in rats.
Ge M; Luo G; Yao W; Luo C; Zhou S; Yuan D; Chi X; Hei Z
Mol Med Rep; 2015 May; 11(5):3962-8. PubMed ID: 25529508
[TBL] [Abstract][Full Text] [Related]
12. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin.
Tanigawa S; Fujii M; Hou DX
Free Radic Biol Med; 2007 Jun; 42(11):1690-703. PubMed ID: 17462537
[TBL] [Abstract][Full Text] [Related]
13. BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress.
Zhang J; Ohta T; Maruyama A; Hosoya T; Nishikawa K; Maher JM; Shibahara S; Itoh K; Yamamoto M
Mol Cell Biol; 2006 Nov; 26(21):7942-52. PubMed ID: 16923960
[TBL] [Abstract][Full Text] [Related]
14. Activation of the KEAP1‑NRF2‑ARE signaling pathway reduces oxidative stress in Hep2 cells.
Li C; Cheng L; Wu H; He P; Zhang Y; Yang Y; Chen J; Chen M
Mol Med Rep; 2018 Sep; 18(3):2541-2550. PubMed ID: 30015918
[TBL] [Abstract][Full Text] [Related]
15. Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells.
Satsu H; Chidachi E; Hiura Y; Ogiwara H; Gondo Y; Shimizu M
Amino Acids; 2012 Oct; 43(4):1547-555. PubMed ID: 22302369
[TBL] [Abstract][Full Text] [Related]
16. The natural compound 2,3,5,4'-tetrahydroxystilbene-2-O-β-d glucoside protects against adriamycin-induced nephropathy through activating the Nrf2-Keap1 antioxidant pathway.
Lin EY; Bayarsengee U; Wang CC; Chiang YH; Cheng CW
Environ Toxicol; 2018 Jan; 33(1):72-82. PubMed ID: 29064158
[TBL] [Abstract][Full Text] [Related]
17. Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway.
Heyninck K; Sabbe L; Chirumamilla CS; Szarc Vel Szic K; Vander Veken P; Lemmens KJA; Lahtela-Kakkonen M; Naulaerts S; Op de Beeck K; Laukens K; Van Camp G; Weseler AR; Bast A; Haenen GRMM; Haegeman G; Vanden Berghe W
Biochem Pharmacol; 2016 Jun; 109():48-61. PubMed ID: 27045103
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of Nrf2 and Keap1 in ARE-mediated NQO1 expression by wasabi 6-(methylsulfinyl)hexyl isothiocyanate.
Hou DX; Korenori Y; Tanigawa S; Yamada-Kato T; Nagai M; He X; He J
J Agric Food Chem; 2011 Nov; 59(22):11975-82. PubMed ID: 22010800
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor erythroid 2-like 2 (Nrf2) expression in end-stage liver disease.
Kurzawski M; Dziedziejko V; Urasińska E; Post M; Wójcicki M; Miętkiewski J; Droździk M
Environ Toxicol Pharmacol; 2012 Jul; 34(1):87-95. PubMed ID: 22459801
[TBL] [Abstract][Full Text] [Related]
20. Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1.
Takagi T; Naito Y; Okada H; Ishii T; Mizushima K; Akagiri S; Adachi S; Handa O; Kokura S; Ichikawa H; Itoh K; Yamamoto M; Matsui H; Yoshikawa T
J Pharmacol Exp Ther; 2009 Oct; 331(1):255-64. PubMed ID: 19628634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
